Some people view the world as something to be acted upon and others as something to work within. The former are engineering us into extinction.

Speak, Shelley, O Great Legislator, speak!

I met a traveller from an antique land
Who said: “Two vast and trunkless legs of stone
Stand in the desert. Near them, on the sand,
Half sunk, a shattered visage lies, whose frown,
And wrinkled lip, and sneer of cold command,
Tell that its sculptor well those passions read
Which yet survive, stamped on these lifeless things,
The hand that mocked them and the heart that fed:
And on the pedestal these words appear:
‘My name is Ozymandias, king of kings:
Look on my works, ye Mighty, and despair!’
Nothing beside remains. Round the decay
Of that colossal wreck, boundless and bare
The lone and level sands stretch far away.”

The new venture called Galvani Bioelectronics will develop implants to treat disorders including arthritis, asthma, and diabetes.Google’s life sciences unit Verily is partnering up with British pharmaceutical giant GlaxoSmithKline for a spinout venture focused on bioelectronic devices. Bioelectronic medicine is a new scientific discipline that seeks to treat a number of chronic diseases including diabetes, asthma, arthritis, and inflammatory bowel disease by using miniature devices implanted in the body that are able to modify the electrical signals of nerves in the body.<a href=”http://www.fastcompany.com/3062383/glaxosmithkline-is-teaming-up-with-googles-verily-to-develop-bioelectronic-medicines?partner=rss

Source: GlaxoSmithKline Is Teaming Up With Google’s Verily To Develop Bioelectronic Medicines